Julie M Cherrington
CIK 1781315 · last filed 2025-07-24
Julie M Cherrington is a corporate insider who has filed 16 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for ELEV, was dated Jul 24, 2025. Across all open-market trades the lifetime net is −$686.9K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
16
-$686.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Elevation Oncology, Inc. (ELEV) Delisted | Director | — | $0.36 | — | $0 | 4 | 2025-07-24 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | Director | 0 | $58.70 | $0 | -$686.9K | 10 | 2024-01-23 |
| Vaxart, Inc. (VXRT) Delisted | Director | 6,217 | $0.32 | $2.0K | $0 | 2 | 2022-08-08 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-24 | Elevation Oncology, Inc. (ELEV) Delisted | Disp (D) | — | $0 | EDGAR |
| 2025-06-09 | Elevation Oncology, Inc. (ELEV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-17 | Elevation Oncology, Inc. (ELEV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-03-04 | Elevation Oncology, Inc. (ELEV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-01-23 | Mirati Therapeutics, Inc. (MRTX) Delisted | Disp (D) | −11,252 | $0 | EDGAR |
| 2024-01-03 | Mirati Therapeutics, Inc. (MRTX) Delisted | Grant (A) | +6,808 | $400.0K | EDGAR |
| 2023-01-24 | Mirati Therapeutics, Inc. (MRTX) Delisted | Grant (A) | +4,444 | $0 | EDGAR |
| 2023-01-20 | Mirati Therapeutics, Inc. (MRTX) Delisted | Sell (S) | −2,546 | -$113.7K | EDGAR |
| 2022-08-08 | Vaxart, Inc. (VXRT) Delisted | Grant (A) | +6,217 | $0 | EDGAR |
| 2022-01-20 | Mirati Therapeutics, Inc. (MRTX) Delisted | Sell (S) | −1,475 | -$171.2K | EDGAR |